Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).

Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH

Open source

DOI
10.1111/1346-8138.14079
Published
2018 Mar
Container
The Journal of dermatology
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1346-8138.14079,
  title = {Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).},
  author = {Ng CY and Tzeng IS and Liu SH and Chang YC and Huang YH},
  year = {2018},
  journal = {The Journal of dermatology},
  doi = {10.1111/1346-8138.14079},
  url = {https://doi.org/10.1111/1346-8138.14079}
}

RIS

TY  - JOUR
TI  - Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).
AU  - Ng CY
AU  - Tzeng IS
AU  - Liu SH
AU  - Chang YC
AU  - Huang YH
PY  - 2018
JO  - The Journal of dermatology
DO  - 10.1111/1346-8138.14079
UR  - https://doi.org/10.1111/1346-8138.14079
ER  - 

APA

CY, N., IS, T., SH, L., YC, C., & YH, H. (2018). Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).. The Journal of dermatology. https://doi.org/10.1111/1346-8138.14079

Source records